{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-25-037163","form_type":"8-K","ticker":"RCKT","cik":"0001281895","company_name":"ROCKET PHARMACEUTICALS, INC.","filed_at":"2025-10-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.023006+00:00","generated_at":"2026-05-17T04:42:42.484433+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Rocket Pharma withdraws BLA for RP-L102 (Fanconi anemia gene therapy) as part of corporate prioritization","bullets":["Voluntarily withdrew BLA for RP-L102 (mozafancogene autotemcel) from FDA on October 3, 2025.","Withdrawal follows prior MAA withdrawal to European Medicines Agency in July 2025 and cessation of new internal investment in RP-L102 in July 2025.","Decision based on business and strategic considerations; no safety or efficacy concerns noted.","Company will explore external partnership opportunities to potentially advance RP-L102 in the future.","Rocket is focusing resources on programs with clearest regulatory and commercial pathways."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-25-037163","json":"https://secwatch.observer/filing/0001140361-25-037163.json","markdown":"https://secwatch.observer/filing/0001140361-25-037163.md","text":"https://secwatch.observer/filing/0001140361-25-037163.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1281895/000114036125037163/0001140361-25-037163-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1281895/000114036125037163/ef20056613_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T04:42:42.484433+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}